• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 4 of 38
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune
Health
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune
By Arthur Allen and Kaiser Health NewsNovember 8, 2022
Europe Omicron vaccine
Health
Europe’s drug regulator set to approve Moderna and Pfizer Omicron boosters this week
By Lyubov Pronina and BloombergAugust 31, 2022
How Zoetis’s CEO is catering to the hands-on millennial pet owner
Newsletters
How Zoetis’s CEO is catering to the hands-on millennial pet owner
By Emma Hinchliffe and Paige McGlauflinAugust 30, 2022
Pfizer-BioNTech ‘surprised’ by Moderna lawsuit alleging they copied COVID-19 vaccine technology
Health
Pfizer-BioNTech ‘surprised’ by Moderna lawsuit alleging they copied COVID-19 vaccine technology
By Chloe TaylorAugust 26, 2022
A vial of the Moderna COVID vaccine
Health
An FDA change to vaccine authorization allowed Pfizer and Moderna to apply for BA.5 booster approval without key data
By Nicholas GordonAugust 24, 2022
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By Paige McGlauflinAugust 15, 2022
COVID finally got me. Will it come for you?
Commentary
COVID finally got me. Will it come for you?
By Carolyn BarberJuly 12, 2022
FDA clears Pfizer and Moderna vaccines for kids under 5
Health
FDA authorizes Pfizer and Moderna COVID vaccines for children under 5
By Fiona Rutherford and BloombergJune 17, 2022
These are the most inspirational CEOs on the Fortune 500
Leadership
These are the most inspirational CEOs on the Fortune 500
By Marco Quiroz-GutierrezMay 26, 2022
Pfizer says it will slash drug prices for the poorest nations. But the devil is in the details
Health
Pfizer says it will slash drug prices for the poorest nations. But the devil is in the details
By Drew Armstrong and BloombergMay 25, 2022
Pfizer vaccine for youngest kids
Health
Pfizer says three COVID shots is ‘highly effective’ in children under 5
By Riley Griffin and BloombergMay 23, 2022
Boy receives COVID-19 vaccine
Health
FDA authorizes Pfizer booster for children ages 5 to 11
By Lauran Neergaard and The Associated PressMay 17, 2022
Companies should be guided by their purpose and values when deciding whether or not to exit Russia
Commentary
Companies should be guided by their purpose and values when deciding whether or not to exit Russia
By Hubert JolyMay 12, 2022
Pfizer CEO says ‘a vaccine that will last at least a year is the holy grail right now’
Health
Pfizer CEO says ‘a vaccine that will last at least a year is the holy grail right now’
By Megan LeonhardtMay 10, 2022
Child receives COVID-19 vaccine
Health
FDA sets June meetings on COVID vaccines for youngest kids
By The Associated PressApril 29, 2022
1
  • 2
  • 3
  • 4
  • 5
  • 6
...38
Most Popular
Real Estate
Meet the 33-year-old CEO betting on boomers chasing their grandkids—and millennials selling their first houseplaceholder alt text
By Nick LichtenbergAugust 8, 2026
Economy
How Scott Bessent used financial engineering to finance the $2 trillion deficit while leaving it untouched—and created a $1.45 trillion shortfallplaceholder alt text
By Eva RoytburgAugust 8, 2026
Economy
With broad bipartisan support, Congress is about to give Trump 'unchecked authority' to impose new tariffs of up to 100% on top trading partnersplaceholder alt text
By Jason MaAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.